498
E.E. Kelley et al. / Free Radical Biology & Medicine 48 (2010) 493–498
[17] Kellogg III, E. W.; Fridovich, I. Superoxide, hydrogen peroxide, and singlet oxygen
in lipid peroxidation by a xanthine oxidase system. J. Biol. Chem. 250:8812–8817;
1975.
[18] Porras, A. G.; Olson, J. S.; Palmer, G. The reaction of reduced xanthine oxidase with
oxygen: kinetics of peroxide and superoxide formation. J. Biol. Chem. 256:
9006–9103; 1981.
Health Grants HL8115 and HL64937 (BAF). The authors thank Joe S.
Moritz, Ph.D., and Keith Inskeep, Ph.D., Division of Animal and
Veterinary Science, West Virginia University (Morgantown, WV, USA)
for both fresh cream and chicken livers used in enzyme purification.
[19] Waud, W. R.; Brady, F. O.; Wiley, R. D.; Rajagopalan, K. V. A new purification
procedure for bovine milk xanthine oxidase: effect of proteolysis on the subunit
structure. Arch. Biochem. Biophys. 169:695–701; 1975.
References
[1] Amaya, Y.; Yamazaki, K.; Sato, M.; Noda, K.; Nishino, T. Proteolytic conversion of
xanthine dehydrogenase from the NAD-dependent type to the O2-dependent
type: amino acid sequence of rat liver xanthine dehydrogenase and identification
of the cleavage sites of the enzyme protein during irreversible conversion by
trypsin. J. Biol. Chem. 265:14170–14175; 1990.
[2] Waud, W. R.; Rajagopalan, K. V. The mechanism of conversion of rat liver xanthine
dehydrogenase from an NAD+-dependent form (type D) to an O2-dependent
form (type O). Arch. Biochem. Biophys. 172:365–379; 1976.
[3] Enroth, C.; Eger, B. T.; Okamoto, K.; Nishino, T.; Nishino, T.; Pai, E. F. Crystal
structures of bovine milk xanthine dehydrogenase and xanthine oxidase:
structure-based mechanism of conversion. Proc. Natl. Acad. Sci. USA 97:
10723–10728; 2000.
[4] Harris, C. M.; Massey, V. The oxidative half-reaction of xanthine dehydrogenase
with NAD: reaction kinetics and steady-state mechanism. J. Biol. Chem. 272:
28335–28341; 1997.
[20] Kelley, E. E.; Trostchansky, A.; Rubbo, H.; Freeman, B. A.; Radi, R.; Tarpey, M. M.
Binding of xanthine oxidase to glycosaminoglycans limits inhibition by oxypur-
inol. J. Biol. Chem. 279:37231–37234; 2004.
[21] Suzuki, H.; DeLano, F. A.; Parks, D. A.; Jamshidi, N.; Granger, D. N.; Ishii, H.;
Suematsu, M.; Zweifach, B. W.; Schmid-Schonbein, G. W. Xanthine oxidase
activity associated with arterial blood pressure in spontaneously hypertensive
rats. Proc. Natl. Acad. Sci. USA 95:4754–4759; 1998.
[22] Kelley, E. E.; Hock, T.; Khoo, N. K. H.; Richardson, G. R.; Johnson, K. K.; Powell, P. C.;
Giles, G. I.; Agarwal, A.; Lancaster Jr., J. R.; Tarpey, M. M. Moderate hypoxia induces
xanthine oxidoreductase activity in arterial endothelial cells. Free Radic. Biol. Med.
40:952–959; 2006.
[23] Kelley, E. E.; Batthyany, C. I.; Hundley, N. J.; Woodcock, S. R.; Bonacci, G.; Del
Rio, J. M.; Schopfer, F. J.; Lancaster Jr., J. R.; Freeman, B. A.; Tarpey, M. M. Nitro-
oleic acid, a novel and irreversible inhibitor of xanthine oxidoreductase. J. Biol.
Chem. 283:36176–36184; 2008.
[5] Butler, R.; Morris, A. D.; Belch, J. J.; Hill, A.; Struthers, A. D. Allopurinol normalizes
endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension
35:746–751; 2000.
[6] Desco, M. C.; Asensi, M.; Marquez, R.; Martinez-Valls, J.; Vento, M.; Pallardo, F. V.;
Sastre, J.; Vina, J. Xanthine oxidase is involved in free radical production in type 1
diabetes: protection by allopurinol. Diabetes 51:1118–1124; 2002.
[7] Farquharson, C. A.; Butler, R.; Hill, A.; Belch, J. J.; Struthers, A. D. Allopurinol
improves endothelial dysfunction in chronic heart failure. Circulation 106:
221–226; 2002.
[24] Radi, R.; Rubbo, H.; Bush, K.; Freeman, B. A. Xanthine oxidase binding to
glycosaminoglycans: kinetics and superoxide dismutase interactions of immobi-
lized xanthine oxidase–heparin complexes. Arch. Biochem. Biophys. 339:125–135;
1997.
[25] Saito, T.; Nishino, T. Differences in redox and kinetic properties between NAD-
dependent and O2-dependent types of rat liver xanthine dehydrogenase. J. Biol.
Chem. 264:10015–10022; 1989.
[26] McCord, J. M.; Fridovich, I. The reduction of cytochrome c by milk xanthine
oxidase. J. Biol. Chem. 243:5753–5760; 1968.
[8] Aslan, M.; Ryan, T. M.; Adler, B.; Townes, T. M.; Parks, D. A.; Thompson, J. A.;
Tousson, A.; Gladwin, M. T.; Patel, R. P.; Tarpey, M. M.; Batinic-Haberle, I.; White,
C. R.; Freeman, B. A. Oxygen radical inhibition of nitric oxide-dependent vascular
function in sickle cell disease. Proc. Natl. Acad. Sci. USA 98:15215–15220; 2001.
[9] Fridovich, I. Quantitative aspects of the production of superoxide anion radical by
milk xanthine oxidase. J. Biol. Chem. 245:4053–4057; 1970.
[27] Hille, R.; Massey, V. Studies on the oxidative half-reaction of xanthine oxidase.
J. Biol. Chem. 256:9090–9095; 1981.
[28] Olson, J. S.; Ballow, D. P.; Palmer, G.; Massey, V. The reaction of xanthine oxidase
with molecular oxygen. J. Biol. Chem. 249:4350–4362; 1974.
[29] Olson, J. S.; Ballou, D. P.; Palmer, G.; Massey, V. The mechanism of action of
xanthine oxidase. J. Biol. Chem. 249:4363–4382; 1974.
[10] McCutchan, H. J.; Schwappach, J. R.; Enquist, E. G.; Walden, D. L.; Terada, L. S.;
Reiss, O. K.; Leff, J. A.; Repine, J. E. Xanthine oxidase-derived H2O2 contributes to
reperfusion injury of ischemic skeletal muscle. Am. J. Physiol. 258:H1415–H1419;
1990.
[11] Brown, J. M.; Terada, L. S.; Grosso, M. A.; Whitmann, G. J.; Velasco, S. E.; Patt, A.;
Harken, A. H.; Repine, J. E. Xanthine oxidase produces hydrogen peroxide which
contributes to reperfusion injury of ischemic, isolated, perfused rat hearts. J. Clin.
Invest. 81:1297–1301; 1988.
[30] Tarpey, M. M.; Fridovich, I. Methods of detection of vascular reactive species:
nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ. Res. 89:
224–236; 2001.
[31] Adachi, T.; Fukushima, T.; Usami, Y.; Hirano, K. Binding of human xanthine oxidase
to sulphated glycosaminoglycans on the endothelial-cell surface. Biochem. J. 289:
523–527; 1993.
[32] Fukushima, T.; Adachi, T.; Hirano, K. The heparin-binding site of human xanthine
oxidase. Biol. Pharm. Bull. 18:156–158; 1995.
[12] Siems, W.; Schmidt, H.; Muller, M.; Henke, W. Gerber, G. H2O2 formation during
nucleotide degradation in the hypoxic rat liver: a quantitative approach. Free
Radic. Res. Commun. 1:289–295; 1986.
[13] Patt, A.; Harken, A. H.; Burton, L. K.; Rodell, T. C.; Piermattei, D.; Schorr, W. J.;
Parker, N. B.; Berger, E. M.; Horesh, I. R.; Terada, L. S. Xanthine oxidase-derived
hydrogen peroxide contributes to ischemia reperfusion-induced edema in gerbil
brains. J. Clin. Invest. 81:1556–1562; 1988.
[33] Houston, M.; Estevez, A.; Chumley, P.; Aslan, M.; Marklund, S.; Parks, D. A.;
Freeman, B. A. Binding of xanthine oxidase to vascular endothelium: kinetic
characterization and oxidative impairment of nitric oxide-dependent signaling.
J. Biol. Chem. 274:4985–4994; 1999.
[34] Camejo, G.; Olsson, U.; Hurt-Camejo, E.; Baharamian, N.; Bondjers, G. The
extracellular matrix on atherogenesis and diabetes-associated vascular disease.
Atherosclerosis (Suppl. 3):3–9; 2002.
[14] Fatokun, A. A.; Stone, T. W.; Smith, R. A. Hydrogen peroxide mediates damage by
xanthine and xanthine oxidase in cerebellar granule neuronal cultures. Neurosci.
Lett. 416:34–38; 2007.
[35] Rhee, S. G.; Kang, S. W.; Jeong, W.; Chang, T. S.; Yang, K. S.; Woo, H. A. Intracellular
messenger function of hydrogen peroxide and its regulation by peroxiredoxins.
Curr. Opin. Cell Biol. 17:183–189; 2005.
[15] Lee, H.; Carlson, J. D.; McMahon, K. K.; Moyer, T. P.; Fischer, A. G. Xanthine oxidase:
a source of hydrogen peroxide in bovine thyroid glands. Life Sci. 20:453–458; 1977.
[16] Lacy, F.; Gough, D. A.; Schmid-Schonbein, G. W. Role of xanthine oxidase in
hydrogen peroxide production. Free Radic. Biol. Med. 25:720–727; 1998.
[36] Forman, H. J.; Torres, M. Reactive oxygen species and cell signaling: respiratory
burst in macrophage signaling. Am. J. Respir. Crit. Care Med. 166:4S–8S; 2002.
[37] Cai, H. Hydrogen peroxide regulation of endothelial function: origins, mechan-
isms, and consequences. Cardiovasc. Res. 68:26–36; 2005.